| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Diamond-Blackfan | 19 | 2020 | 137 | 3.240 |
Why?
|
| Ribosomal Proteins | 14 | 2018 | 360 | 1.400 |
Why?
|
| Bone Marrow Diseases | 5 | 2018 | 231 | 1.330 |
Why?
|
| Anemia, Aplastic | 7 | 2018 | 226 | 1.300 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 2018 | 102 | 1.210 |
Why?
|
| Colony-Stimulating Factors | 18 | 1994 | 221 | 1.030 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 587 | 0.910 |
Why?
|
| Hematopoietic Stem Cells | 33 | 2019 | 3386 | 0.840 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 8 | 2005 | 110 | 0.810 |
Why?
|
| Interleukin-3 | 18 | 2005 | 444 | 0.790 |
Why?
|
| Hematopoiesis | 22 | 2019 | 2072 | 0.750 |
Why?
|
| Fanconi Anemia | 7 | 2001 | 319 | 0.700 |
Why?
|
| Erythropoiesis | 15 | 2017 | 705 | 0.690 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2016 | 12 | 0.590 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2016 | 125 | 0.560 |
Why?
|
| Receptors, Erythropoietin | 5 | 1997 | 147 | 0.550 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2016 | 116 | 0.530 |
Why?
|
| Bone Marrow | 15 | 2019 | 2948 | 0.520 |
Why?
|
| Mutation | 17 | 2019 | 29786 | 0.470 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 565 | 0.450 |
Why?
|
| Hematopoietic Cell Growth Factors | 6 | 1993 | 102 | 0.430 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 15 | 1998 | 903 | 0.400 |
Why?
|
| Bone Marrow Cells | 18 | 2006 | 2513 | 0.360 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2018 | 1352 | 0.350 |
Why?
|
| Tissue Donors | 3 | 2018 | 2240 | 0.350 |
Why?
|
| Antigens, CD34 | 10 | 2019 | 657 | 0.300 |
Why?
|
| Growth Substances | 10 | 1994 | 784 | 0.270 |
Why?
|
| Granulocytes | 9 | 2019 | 548 | 0.270 |
Why?
|
| Neutrophils | 2 | 2016 | 3719 | 0.260 |
Why?
|
| Erythropoietin | 8 | 2005 | 726 | 0.260 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2018 | 5442 | 0.260 |
Why?
|
| Antigens, Surface | 6 | 1986 | 1663 | 0.260 |
Why?
|
| Recombinant Proteins | 16 | 1997 | 6622 | 0.250 |
Why?
|
| Anemia, Sideroblastic | 3 | 2018 | 101 | 0.240 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2018 | 3523 | 0.230 |
Why?
|
| GATA1 Transcription Factor | 3 | 2014 | 293 | 0.220 |
Why?
|
| Erythroid Precursor Cells | 5 | 2006 | 218 | 0.220 |
Why?
|
| Interleukin-1 | 6 | 1991 | 1263 | 0.210 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 80 | 0.200 |
Why?
|
| Cells, Cultured | 23 | 2015 | 19229 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 5 | 1998 | 3772 | 0.190 |
Why?
|
| Receptors, Virus | 2 | 2005 | 648 | 0.190 |
Why?
|
| Cell Division | 12 | 1999 | 4568 | 0.190 |
Why?
|
| Antigens, CD | 6 | 2015 | 4026 | 0.180 |
Why?
|
| Gene Expression Regulation | 9 | 2006 | 12072 | 0.180 |
Why?
|
| Colony-Forming Units Assay | 13 | 2000 | 356 | 0.180 |
Why?
|
| Mutation, Missense | 3 | 2019 | 2564 | 0.180 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 1999 | 30 | 0.170 |
Why?
|
| Gene Transfer Techniques | 3 | 2000 | 1224 | 0.170 |
Why?
|
| Leucine | 2 | 2020 | 561 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2001 | 460 | 0.170 |
Why?
|
| Moloney murine leukemia virus | 1 | 1999 | 139 | 0.170 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1999 | 94 | 0.170 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2019 | 69 | 0.170 |
Why?
|
| Spectrin | 1 | 2019 | 177 | 0.170 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2018 | 10 | 0.170 |
Why?
|
| Portraits as Topic | 1 | 2018 | 33 | 0.160 |
Why?
|
| MELAS Syndrome | 1 | 2018 | 50 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 209 | 0.160 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1997 | 30 | 0.160 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 442 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2005 | 1951 | 0.150 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 733 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3920 | 0.150 |
Why?
|
| Receptors, Transferrin | 3 | 2015 | 296 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 595 | 0.150 |
Why?
|
| Acidosis, Lactic | 1 | 2018 | 142 | 0.140 |
Why?
|
| Capsid | 1 | 1999 | 436 | 0.140 |
Why?
|
| Thrombophilia | 1 | 2019 | 305 | 0.140 |
Why?
|
| Siblings | 2 | 2018 | 854 | 0.140 |
Why?
|
| RNA Interference | 1 | 2005 | 2889 | 0.140 |
Why?
|
| Humans | 105 | 2021 | 744343 | 0.130 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 245 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 635 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 644 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2015 | 547 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4751 | 0.130 |
Why?
|
| Blood Transfusion | 2 | 2020 | 1301 | 0.120 |
Why?
|
| Cell Differentiation | 16 | 2019 | 11483 | 0.120 |
Why?
|
| RNA, Ribosomal | 2 | 2013 | 246 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2018 | 372 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2019 | 907 | 0.120 |
Why?
|
| Methionine | 1 | 2016 | 590 | 0.120 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1993 | 43 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2016 | 527 | 0.120 |
Why?
|
| Stem Cell Factor | 3 | 2005 | 219 | 0.110 |
Why?
|
| Homocysteine | 1 | 2016 | 647 | 0.110 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 2126 | 0.110 |
Why?
|
| RNA, Messenger | 11 | 2014 | 13033 | 0.110 |
Why?
|
| Arthroscopy | 1 | 2019 | 926 | 0.110 |
Why?
|
| Pedigree | 6 | 2015 | 4644 | 0.110 |
Why?
|
| Ribosomes | 3 | 2018 | 500 | 0.100 |
Why?
|
| Hip Joint | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 996 | 0.100 |
Why?
|
| Cell Line | 11 | 2008 | 15997 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Genetic Linkage | 4 | 2006 | 2421 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1678 | 0.100 |
Why?
|
| Cell Cycle | 3 | 1999 | 2967 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 1986 | 1475 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 1999 | 3768 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 2948 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1788 | 0.090 |
Why?
|
| Receptors, Colony-Stimulating Factor | 4 | 1994 | 49 | 0.090 |
Why?
|
| Genes, myb | 1 | 2009 | 18 | 0.090 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 399 | 0.090 |
Why?
|
| T-Lymphocytes | 11 | 1999 | 10180 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2018 | 2751 | 0.090 |
Why?
|
| Exons | 2 | 2018 | 2437 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 1999 | 3420 | 0.090 |
Why?
|
| Globins | 3 | 2017 | 415 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3505 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 8 | 2000 | 2765 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 18111 | 0.080 |
Why?
|
| Transfection | 5 | 1996 | 5892 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1655 | 0.080 |
Why?
|
| Infant | 14 | 2018 | 35136 | 0.080 |
Why?
|
| DNA Mutational Analysis | 4 | 2012 | 4186 | 0.080 |
Why?
|
| Glycoproteins | 3 | 1987 | 2263 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1058 | 0.080 |
Why?
|
| G1 Phase | 1 | 2009 | 415 | 0.080 |
Why?
|
| Leukemia | 5 | 1997 | 1511 | 0.080 |
Why?
|
| Base Sequence | 6 | 2012 | 12797 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2019 | 23403 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1988 | 4420 | 0.080 |
Why?
|
| Fibroblasts | 6 | 2015 | 4161 | 0.080 |
Why?
|
| Animals | 33 | 2015 | 168757 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 4554 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 562 | 0.070 |
Why?
|
| Thumb | 1 | 2008 | 227 | 0.070 |
Why?
|
| Mice | 18 | 2006 | 81183 | 0.070 |
Why?
|
| Haplotypes | 2 | 2004 | 2779 | 0.070 |
Why?
|
| Erythroblasts | 3 | 1999 | 150 | 0.070 |
Why?
|
| Endothelium, Vascular | 3 | 1988 | 4456 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2453 | 0.070 |
Why?
|
| Clone Cells | 4 | 1999 | 1692 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2019 | 8436 | 0.070 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1983 | 189 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 898 | 0.070 |
Why?
|
| Mesoderm | 1 | 1988 | 686 | 0.070 |
Why?
|
| Interleukins | 1 | 1990 | 791 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2012 | 5179 | 0.060 |
Why?
|
| Erythrocytes | 6 | 1987 | 2455 | 0.060 |
Why?
|
| Stem Cells | 4 | 2005 | 3567 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2009 | 10481 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 5 | 1997 | 648 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 1416 | 0.060 |
Why?
|
| Macrophages | 5 | 1995 | 5655 | 0.060 |
Why?
|
| Retroviridae | 2 | 2005 | 914 | 0.060 |
Why?
|
| Endothelium | 1 | 1987 | 778 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 2012 | 1581 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 1993 | 1580 | 0.060 |
Why?
|
| Cell Separation | 8 | 2006 | 1751 | 0.060 |
Why?
|
| Fibronectins | 1 | 1987 | 726 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2019 | 2504 | 0.060 |
Why?
|
| Osteopetrosis | 1 | 1983 | 43 | 0.060 |
Why?
|
| K562 Cells | 1 | 2005 | 634 | 0.060 |
Why?
|
| Drug Synergism | 4 | 1994 | 1792 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 10 | 1994 | 9274 | 0.060 |
Why?
|
| Cleft Palate | 1 | 2008 | 560 | 0.060 |
Why?
|
| RNA | 2 | 2009 | 2749 | 0.060 |
Why?
|
| Genetic Association Studies | 3 | 2018 | 2703 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 733 | 0.050 |
Why?
|
| Monocytes | 5 | 2019 | 2596 | 0.050 |
Why?
|
| Male | 29 | 2020 | 350118 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4328 | 0.050 |
Why?
|
| Introns | 1 | 2005 | 991 | 0.050 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1981 | 80 | 0.050 |
Why?
|
| Flow Cytometry | 6 | 2005 | 5974 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1117 | 0.050 |
Why?
|
| Cations | 1 | 2021 | 232 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 2050 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 4740 | 0.050 |
Why?
|
| Receptors, Cell Surface | 4 | 2000 | 2866 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 2012 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4149 | 0.050 |
Why?
|
| Lod Score | 1 | 2001 | 614 | 0.050 |
Why?
|
| Dyskeratosis Congenita | 1 | 2000 | 72 | 0.040 |
Why?
|
| Cell Membrane | 3 | 1987 | 3748 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 367 | 0.040 |
Why?
|
| Killer Cells, Natural | 4 | 1999 | 2133 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1028 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2006 | 14557 | 0.040 |
Why?
|
| Permeability | 1 | 2021 | 738 | 0.040 |
Why?
|
| Female | 27 | 2020 | 380194 | 0.040 |
Why?
|
| Reference Values | 1 | 2006 | 4982 | 0.040 |
Why?
|
| Cyclophosphamide | 3 | 1997 | 2242 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 1999 | 264 | 0.040 |
Why?
|
| Liver | 3 | 2009 | 7474 | 0.040 |
Why?
|
| Primary Myelofibrosis | 1 | 1980 | 215 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 13815 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2000 | 350 | 0.040 |
Why?
|
| Phenotype | 7 | 2018 | 16365 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8642 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2012 | 21746 | 0.040 |
Why?
|
| Adolescent | 12 | 2020 | 85781 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 1989 | 193 | 0.040 |
Why?
|
| Blood Specimen Collection | 2 | 1997 | 246 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 23 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3002 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1999 | 357 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 342 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 7722 | 0.040 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2019 | 339 | 0.040 |
Why?
|
| Time Factors | 7 | 2005 | 40075 | 0.040 |
Why?
|
| Culture Media | 3 | 1989 | 908 | 0.040 |
Why?
|
| Interleukin-2 | 5 | 1996 | 1904 | 0.040 |
Why?
|
| Thymidine | 1 | 1996 | 310 | 0.040 |
Why?
|
| Child, Preschool | 9 | 2020 | 41006 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1996 | 104 | 0.030 |
Why?
|
| Janus Kinase 2 | 2 | 1996 | 528 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2013 | 3128 | 0.030 |
Why?
|
| Bone Marrow Purging | 2 | 1996 | 109 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 2000 | 803 | 0.030 |
Why?
|
| Blood Component Removal | 1 | 1997 | 125 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2010 | 436 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 457 | 0.030 |
Why?
|
| Child | 14 | 2020 | 77709 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1996 | 169 | 0.030 |
Why?
|
| Heterozygote | 2 | 2019 | 2804 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4217 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2000 | 1099 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2107 | 0.030 |
Why?
|
| Stromal Cells | 2 | 1998 | 1355 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3462 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2839 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2017 | 238 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1996 | 364 | 0.030 |
Why?
|
| Myeloproliferative Disorders | 1 | 1981 | 606 | 0.030 |
Why?
|
| Neutropenia | 1 | 2000 | 895 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1097 | 0.030 |
Why?
|
| Platelet Count | 2 | 1998 | 781 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1981 | 1813 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2001 | 2634 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 1878 | 0.030 |
Why?
|
| HLA Antigens | 4 | 1986 | 1381 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 21827 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 1994 | 63 | 0.030 |
Why?
|
| Lymphocytes | 7 | 1998 | 2617 | 0.030 |
Why?
|
| Syndrome | 1 | 2000 | 3251 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5853 | 0.030 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 2 | 1986 | 153 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1994 | 642 | 0.030 |
Why?
|
| Isoantigens | 1 | 1996 | 567 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1999 | 2716 | 0.030 |
Why?
|
| Apoptosis | 2 | 2008 | 9727 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 424 | 0.030 |
Why?
|
| Adult | 17 | 2020 | 214055 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 1995 | 1588 | 0.030 |
Why?
|
| Tyrosine | 2 | 1996 | 1461 | 0.030 |
Why?
|
| Graft vs Host Disease | 3 | 1996 | 2957 | 0.030 |
Why?
|
| Aftercare | 1 | 2019 | 866 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 1366 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1866 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2000 | 25625 | 0.030 |
Why?
|
| DNA | 4 | 2008 | 7301 | 0.030 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 492 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 496 | 0.030 |
Why?
|
| Genomic Library | 1 | 1991 | 193 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 56430 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 749 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2007 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1676 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 3 | 1991 | 523 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 1996 | 970 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 985 | 0.020 |
Why?
|
| Blood Proteins | 3 | 1986 | 1124 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 1994 | 651 | 0.020 |
Why?
|
| Sialoglycoproteins | 2 | 1983 | 318 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2013 | 786 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 2382 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 713 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1993 | 2505 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1998 | 1179 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3129 | 0.020 |
Why?
|
| Graft Survival | 2 | 1999 | 3737 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 2255 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 1990 | 3206 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 1996 | 1284 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1454 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1085 | 0.020 |
Why?
|
| Quinazolines | 1 | 2017 | 1356 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1996 | 2455 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2924 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1990 | 174 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1995 | 689 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1836 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1994 | 2008 | 0.020 |
Why?
|
| Ribosome Subunits, Large | 1 | 2008 | 5 | 0.020 |
Why?
|
| Ribosome Subunits, Small | 1 | 2008 | 5 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 1998 | 9648 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1993 | 1539 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1998 | 10943 | 0.020 |
Why?
|
| Phagocytes | 1 | 1990 | 297 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1300 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1821 | 0.020 |
Why?
|
| Cell Survival | 1 | 1999 | 5882 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1996 | 901 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39050 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9583 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1996 | 4011 | 0.020 |
Why?
|
| Hylobates | 1 | 1987 | 13 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2001 | 3444 | 0.020 |
Why?
|
| Estrogens | 1 | 1995 | 1566 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1381 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1832 | 0.020 |
Why?
|
| Prognosis | 3 | 2020 | 29063 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1988 | 829 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 326 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1526 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1995 | 1415 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18029 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1988 | 322 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 2187 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6171 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1994 | 1990 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2006 | 62 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 1671 | 0.020 |
Why?
|
| Nucleoside Transport Proteins | 1 | 1986 | 7 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 2 | 1981 | 1041 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1988 | 403 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1988 | 437 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1987 | 433 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2006 | 78 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 1986 | 244 | 0.020 |
Why?
|
| Anemia | 1 | 2015 | 1506 | 0.020 |
Why?
|
| Point Mutation | 2 | 2005 | 1623 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1991 | 1758 | 0.020 |
Why?
|
| Proteins | 2 | 1998 | 6103 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 498 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 218 | 0.020 |
Why?
|
| Giant Cell Tumors | 1 | 1986 | 99 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2916 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1736 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 1899 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 1423 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5524 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1986 | 378 | 0.020 |
Why?
|
| Cytokines | 1 | 2000 | 7322 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 1941 | 0.020 |
Why?
|
| Cricetulus | 1 | 1986 | 816 | 0.020 |
Why?
|
| Blood Group Antigens | 1 | 1986 | 180 | 0.020 |
Why?
|
| Protein Binding | 1 | 1996 | 9386 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 906 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1987 | 973 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2019 | 4599 | 0.010 |
Why?
|
| Heme | 1 | 2005 | 307 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 6473 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1401 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 513 | 0.010 |
Why?
|
| I Blood-Group System | 1 | 1982 | 8 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 767 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 658 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1983 | 220 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1893 | 0.010 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1983 | 107 | 0.010 |
Why?
|
| Receptors, Fc | 2 | 1989 | 541 | 0.010 |
Why?
|
| Cricetinae | 1 | 1986 | 2472 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4665 | 0.010 |
Why?
|
| X Chromosome | 3 | 1995 | 814 | 0.010 |
Why?
|
| Placenta | 1 | 1991 | 1698 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 3703 | 0.010 |
Why?
|
| Middle Aged | 8 | 2020 | 213383 | 0.010 |
Why?
|
| Tumor Virus Infections | 2 | 1981 | 452 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 40561 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4320 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 959 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1983 | 517 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1988 | 2216 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1982 | 645 | 0.010 |
Why?
|
| Forearm | 1 | 1983 | 409 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1282 | 0.010 |
Why?
|
| Antigens, Differentiation | 2 | 1996 | 927 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1997 | 403 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1982 | 367 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1986 | 1602 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2000 | 151 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3144 | 0.010 |
Why?
|
| Karyotyping | 1 | 1981 | 1243 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10638 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2000 | 131 | 0.010 |
Why?
|
| Rosette Formation | 3 | 1986 | 153 | 0.010 |
Why?
|
| Cell Communication | 1 | 1986 | 1621 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 1998 | 100 | 0.010 |
Why?
|
| Immune Sera | 1 | 1998 | 641 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2000 | 477 | 0.010 |
Why?
|
| Mitomycin | 1 | 1998 | 259 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1990 | 719 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 684 | 0.010 |
Why?
|
| Epitopes | 2 | 1981 | 2571 | 0.010 |
Why?
|
| Hematocrit | 1 | 1998 | 636 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 21683 | 0.010 |
Why?
|
| Cell Count | 2 | 1995 | 1856 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 103 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1996 | 517 | 0.010 |
Why?
|
| Leukapheresis | 1 | 1995 | 131 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1997 | 961 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1995 | 198 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1995 | 12208 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 6314 | 0.010 |
Why?
|
| Immunization | 1 | 1980 | 1256 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1995 | 68 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 257 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1996 | 365 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1983 | 4776 | 0.010 |
Why?
|
| Rabbits | 1 | 1981 | 4894 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1341 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 211 | 0.010 |
Why?
|
| Spleen | 1 | 2000 | 2362 | 0.010 |
Why?
|
| Antibodies, Viral | 2 | 1981 | 3176 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1995 | 207 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 2478 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 865 | 0.010 |
Why?
|
| Genome, Human | 1 | 2006 | 4420 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1981 | 1988 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1996 | 1547 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1996 | 1147 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1997 | 850 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1981 | 4560 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72290 | 0.010 |
Why?
|
| Tretinoin | 1 | 1995 | 517 | 0.010 |
Why?
|
| Radiography | 1 | 1983 | 7023 | 0.010 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1990 | 17 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1997 | 2375 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1991 | 448 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1991 | 262 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 4933 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1995 | 2124 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1917 | 0.010 |
Why?
|
| Superoxides | 1 | 1990 | 387 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 29144 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1991 | 608 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1994 | 1619 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1990 | 647 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1986 | 7880 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1058 | 0.010 |
Why?
|
| Fetus | 2 | 1986 | 1880 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1996 | 896 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 19905 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1375 | 0.000 |
Why?
|
| Swine | 1 | 1997 | 5917 | 0.000 |
Why?
|
| Cell Fractionation | 1 | 1987 | 252 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1983 | 4445 | 0.000 |
Why?
|
| Tritium | 1 | 1987 | 745 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1991 | 1402 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1986 | 115 | 0.000 |
Why?
|
| Receptors, IgG | 1 | 1989 | 582 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 1369 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2274 | 0.000 |
Why?
|
| Fetal Hemoglobin | 1 | 1987 | 341 | 0.000 |
Why?
|
| Thioguanine | 1 | 1983 | 46 | 0.000 |
Why?
|
| Interferon Type I | 1 | 1987 | 542 | 0.000 |
Why?
|
| Daunorubicin | 1 | 1983 | 158 | 0.000 |
Why?
|
| Aged | 3 | 2005 | 163280 | 0.000 |
Why?
|
| Photomicrography | 1 | 1981 | 74 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1987 | 986 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1996 | 3481 | 0.000 |
Why?
|
| Infectious Mononucleosis | 1 | 1981 | 131 | 0.000 |
Why?
|
| Cytarabine | 1 | 1983 | 692 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1981 | 315 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1987 | 1318 | 0.000 |
Why?
|
| Agammaglobulinemia | 1 | 1981 | 167 | 0.000 |
Why?
|
| Antigens | 1 | 1986 | 1466 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1996 | 4838 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1983 | 13695 | 0.000 |
Why?
|
| Skin | 1 | 1991 | 4364 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1981 | 992 | 0.000 |
Why?
|
| Interferons | 1 | 1981 | 706 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1981 | 1035 | 0.000 |
Why?
|
| Sheep | 1 | 1980 | 1437 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1981 | 1537 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1981 | 1607 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 11124 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1983 | 6489 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 13102 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1981 | 2958 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 20822 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1983 | 11031 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1983 | 7913 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1981 | 9146 | 0.000 |
Why?
|